Bluprynt | $4,250,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
Revel(US) | $150,000,000 | (Feb 27, 2026)
Certified by Founder
Lodge
SolasCure
start up
United Kingdom
- Cambridge
- 28/03/2023
- Series B
- $13,422,000
SolasCure leverages biomimicry and evidence-based medicine to develop fit for purpose, efficacious wound care products significantly improve the health and wellbeing of patients.
- Industry Biotechnology Research
- Website https://solascure.com/
- LinkedIn https://www.linkedin.com/company/solascure/
Related People
Sam BakriFounder
United Kingdom -
Cambridge, England
Experienced executive and entrepreneur in life sciences, founded and exited life sciences companies in biopharmaceutical and medical devices.
Alpa | $3,500,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
Callosum | $10,250,000 | (Feb 27, 2026)
JetScale AI | $5,400,000 | (Feb 27, 2026)
Dots | $8,900,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
Ark Climate | $2,478,315 | (Feb 27, 2026)
Jest | $7,000,000 | (Feb 27, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)